These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19134533)

  • 1. Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection.
    Pelaez A; Lyon GM; Force SD; Ramirez AM; Neujahr DC; Foster M; Naik PM; Gal AA; Mitchell PO; Lawrence EC
    J Heart Lung Transplant; 2009 Jan; 28(1):67-71. PubMed ID: 19134533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
    Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
    J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency.
    Burrows FS; Carlos LM; Benzimra M; Marriott DJ; Havryk AP; Plit ML; Malouf MA; Glanville AR
    J Heart Lung Transplant; 2015 Jul; 34(7):958-62. PubMed ID: 25753833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
    Liu V; Dhillon GS; Weill D
    Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral and Inhaled Ribavirin Treatment for Respiratory Syncytial Virus Infection in Lung Transplant Recipients.
    Permpalung N; Thaniyavarn T; Saullo JL; Arif S; Miller RA; Reynolds JM; Alexander BD
    Transplantation; 2020 Jun; 104(6):1280-1286. PubMed ID: 31568275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation.
    Li L; Avery R; Budev M; Mossad S; Danziger-Isakov L
    J Heart Lung Transplant; 2012 Aug; 31(8):839-44. PubMed ID: 22621746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy.
    Uçkay I; Gasche-Soccal PM; Kaiser L; Stern R; Mazza-Stalder J; Aubert JD; van Delden C
    J Heart Lung Transplant; 2010 Mar; 29(3):299-305. PubMed ID: 19837611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin.
    McCurdy LH; Milstone A; Dummer S
    J Heart Lung Transplant; 2003 Jul; 22(7):745-53. PubMed ID: 12873542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients.
    Damlaj M; Bartoo G; Cartin-Ceba R; Gijima D; Alkhateeb HB; Merten J; Hashmi S; Litzow M; Gastineau D; Hogan W; Patnaik MM
    Transpl Infect Dis; 2016 Apr; 18(2):216-26. PubMed ID: 26909896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.
    Foolad F; Aitken SL; Shigle TL; Prayag A; Ghantoji S; Ariza-Heredia E; Chemaly RF
    Clin Infect Dis; 2019 May; 68(10):1641-1649. PubMed ID: 30202920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of aerosolized versus oral ribavirin for the treatment of respiratory syncytial virus infections: A single-center retrospective cohort study and review of the literature.
    Trang TP; Whalen M; Hilts-Horeczko A; Doernberg SB; Liu C
    Transpl Infect Dis; 2018 Apr; 20(2):e12844. PubMed ID: 29360277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribavirin and cellular ribavirin-triphosphate concentrations in blood and bronchoalveolar lavage fluid in two lung transplant patients with respiratory syncytial virus.
    Mueller SW; Kiser TH; Morrisette T; Zamora MR; Lyu DM; Kiser JJ
    Transpl Infect Dis; 2021 Feb; 23(1):e13464. PubMed ID: 32920958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients.
    Marcelin JR; Wilson JW; Razonable RR;
    Transpl Infect Dis; 2014 Apr; 16(2):242-50. PubMed ID: 24621016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database.
    Law BJ; Wang EE; MacDonald N; McDonald J; Dobson S; Boucher F; Langley J; Robinson J; Mitchell I; Stephens D
    Pediatrics; 1997 Mar; 99(3):E7. PubMed ID: 9099772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative.
    Beaird OE; Freifeld A; Ison MG; Lawrence SJ; Theodoropoulos N; Clark NM; Razonable RR; Alangaden G; Miller R; Smith J; Young JA; Hawkinson D; Pursell K; Kaul DR
    Transpl Infect Dis; 2016 Apr; 18(2):210-5. PubMed ID: 26923867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipients.
    Gorcea CM; Tholouli E; Turner A; Saif M; Davies E; Battersby E; Dignan FL
    J Hosp Infect; 2017 Feb; 95(2):214-217. PubMed ID: 28077243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients.
    Gottlieb J; Zamora MR; Hodges T; Musk AW; Sommerwerk U; Dilling D; Arcasoy S; DeVincenzo J; Karsten V; Shah S; Bettencourt BR; Cehelsky J; Nochur S; Gollob J; Vaishnaw A; Simon AR; Glanville AR
    J Heart Lung Transplant; 2016 Feb; 35(2):213-21. PubMed ID: 26452996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
    Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
    Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference therapy in lung transplant patients infected with respiratory syncytial virus.
    Zamora MR; Budev M; Rolfe M; Gottlieb J; Humar A; Devincenzo J; Vaishnaw A; Cehelsky J; Albert G; Nochur S; Gollob JA; Glanville AR
    Am J Respir Crit Care Med; 2011 Feb; 183(4):531-8. PubMed ID: 20851929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
    Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
    Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.